Compound ID | 2700
Class: Beta-lactam
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against penicillin-resistant and -susceptible Staphylococcus aureus (resistant to penicillinase activity) |
| Description: | Semisynthetic compound prepared from 6-aminopenicillanic acid (6-APA) and quinoxaline-2,3-dicarboxylic anhydride; a derivative of penicillin; effective in treating staphylococcal infection when administered parenterally; poorly absorbed orally; successful clinical trials (1966) but current status of drug unknown |
| Institute where first reported: | Boots Pure Drug Co., Nottingham |
| Year first mentioned: | 1963 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|